Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUniphar Regulatory News (UPR)

Share Price Information for Uniphar (UPR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 223.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 6.00 (2.727%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 223.00
UPR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

14 Sep 2023 15:00

RNS Number : 5019M
Uniphar PLC
14 September 2023
 

Standard Form TR-1 Voting rights attached to shares- Article 12(1) of directive 2004/109/ECFinancial instruments - Article 11(3) of the Commission Directive 2007/14/EC[i]

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached [ii]:

UNIPHAR PLC

2. Reason for the notification (please tick the appropriate box or boxes):

[ X ] an acquisition or disposal of voting rights

[ ] an acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

[ ] an event changing the breakdown of voting rights

3. Full name of person(s) subject to the notification obligation[iii]:

BlackRock, Inc.

4. Full name of shareholder(s) (if different from 3.)[iv]:

See Section 9

5. Date of the transaction and date on which the threshold is crossed or reached[v]: 13/09/2023

6. Date on which issuer notified: 14/09/2023

7. Threshold(s) that is/are crossed or reached:

Holdings for BlackRock, Inc. have gone below 3%.

8. Notified details:

1.

1. 1. 1.

A) Voting rights attached to shares

Class/type of shares (if possible using the ISIN CODE)

Situation previous to the Triggering transaction [vi]

Resulting situation after the triggering transaction[vii][viii]

Number of Shares[ix]

Number of Voting rights[x]

Number of shares[xi]

Number of voting rights[xii]

% of voting rights

Direct

Direct[xiii]

Indirect[xiv]

Direct

Indirect

IE00BJ5FQX74

N/A

8,205,205

N/A

N/A

Below3%

N/A

Below3%

SUBTOTAL A (based on aggregate voting rights)

Below3%

Below3%

 

B) Financial Instruments

Resulting situation after the triggering transaction[xv]

Type of financial instrument

Expiration Date[xvi]

Exercise/Conversion Period/ Date[xvii]

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

SUBTOTAL B (in relation to all expiration dates)

 

Total (A+B)

number of voting rights

% of voting rights

Below3%

Below3%

Below3%

 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable[xviii]:

 

Each of the following entities, which are wholly owned subsidiaries of BlackRock, Inc., hold the following interests in voting rights in their capacity as Investment Manager on behalf of clients:

Investment Manager

Voting Rights

%

BlackRock Advisors (UK) Limited

Below 3%

Below 3%

BlackRock Asset Management Canada Limited

Below 3%

Below 3%

BlackRock Fund Advisors

Below 3%

Below 3%

BlackRock Institutional Trust Company, National Association

Below 3%

Below 3%

BlackRock Investment Management (UK) Limited

Below 3%

Below 3%

BlackRock Investment Management, LLC

Below 3%

Below 3%

 

 

10. In case of proxy voting: [name of the proxy holder] will cease to hold [number] voting rights as of [date].

11. Additional information:

Decrease in holding following client instruction to elect for decision making on voting rights.

Done at 12 Throgmorton Avenue, London, EC2N 2DL, U.K. on 14 September 2023

 

 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLNKQBQNBKDPCD
Date   Source Headline
26th Apr 20241:48 pmRNSHolding(s) in Company
15th Apr 20249:00 amRNSDirector/PDMR Shareholding
5th Apr 20247:00 amRNSNotice of AGM & Annual Report
27th Feb 20247:00 amRNS2023 Preliminary Results
6th Feb 202410:30 amRNSHolding(s) in Company
30th Jan 20247:00 amRNSDirectorate Change
30th Jan 20247:00 amRNSFull Year Trading Update and Notice of Results
17th Jan 20247:00 amRNSDirectorate Change
24th Nov 202311:20 amRNSHolding(s) in Company
9th Oct 202311:00 amRNSDirector/PDMR Shareholding
6th Oct 20237:00 amRNSDirector/PDMR Shareholding
4th Oct 20237:00 amRNSDirector/PDMR Shareholding
21st Sep 20233:33 pmRNSHolding(s) in Company
19th Sep 20239:29 amRNSHolding(s) in Company
14th Sep 20233:00 pmRNSHolding(s) in Company
14th Sep 20237:00 amRNS2023 Interim Results
4th Sep 20237:00 amRNSHolding(s) in Company
1st Aug 20232:45 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSHalf Year Trading Update and Notice of Results
14th Jun 20235:00 pmRNSHolding(s) in Company
11th May 20233:32 pmRNSAGM Results
11th May 20237:00 amRNSAGM Statement
3rd May 20237:00 amRNSHolding(s) in Company
6th Apr 20237:00 amRNSNotice of AGM & Annual Report & Dividend Update
3rd Mar 20237:00 amRNSExecutive Restricted Share Plan Dealings
1st Mar 20233:00 pmRNSDirector/PDMR Shareholding
28th Feb 20237:00 amRNS2022 Preliminary Results
3rd Feb 20237:00 amRNSHolding(s) in Company
2nd Feb 20237:00 amRNSCompletion of McCauley Acquisition
31st Jan 20237:00 amRNSFull Year Trading Update and Notice of Results
25th Jan 20237:00 amRNSHolding(s) in Company
16th Dec 20227:00 amRNSNavi acquisition not cleared by CCPC
8th Dec 20224:06 pmRNSHolding(s) in Company
2nd Dec 20227:00 amRNSNew Share Option Plan
21st Nov 20227:00 amRNSAcquisition of BModesto Group
4th Oct 20227:00 amRNSAcquisition of healthcare agency Inspired Health
19th Sep 20227:00 amRNSAcquisition of McCauley Pharmacy Group
14th Sep 20229:08 amRNSDirector/PDMR Shareholding
30th Aug 20227:00 amRNS2022 Interim Results
26th Jul 20227:00 amRNSHalf Year Trading Update and Notice of Results
11th May 20224:16 pmRNSResult of AGM
11th May 20227:00 amRNSAGM Statement
7th Apr 20227:00 amRNSNotice of AGM & Annual Report
3rd Mar 20227:31 amRNSDirector/PDMR Shareholding
3rd Mar 20227:29 amRNSExecutive Restricted Share Plan Dealings
1st Mar 20227:00 amRNS2021 Preliminary Results
21st Feb 20228:00 amRNSHolding(s) in Company
26th Jan 20227:00 amRNSFull Year Trading Update & Notice of Results
23rd Dec 20217:00 amRNSAcquisitions of E4H, Devonshire and Navi Group
17th Dec 20217:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.